Occurrence of Parkinson's syndrome in type 1 Gaucher disease
Orit Neudorfer(Shaare Zedek Medical Center), Nir Giladi(Shaare Zedek Medical Center), Deborah Elstein(Shaare Zedek Medical Center), Aya Abrahamov(Shaare Zedek Medical Center), T. Turezkite(Carmel Medical Center), E Aghai(Carmel Medical Center), A. Reches(Shaare Zedek Medical Center), Bruno Bembi(IRCCS Materno Infantile Burlo Garofolo), Ari Zimran(Shaare Zedek Medical Center)
Cited by 394Open Access
Abstract
Gaucher disease, the most prevalent glycolipid storage disorder, is classically subdivided into types according to the presence or absence of neurological involvement. Type I has hitherto been considered non-neuronopathic. We present six cases and a review of the literature of Parkinsonian symptoms in type I Gaucher disease patients. The hallmark of this atypical Parkinsonian syndrome is a relatively severe clinical course with early appearance of neurological signs in the 4th to 6th decade of life, aggressive progression of the signs and refractoriness to conventional anti-Parkinson therapy. We discuss the implications of these findings in the light of enzyme replacement therapy for Gaucher disease.
Related Papers
Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's Disease
Norman W. Barton, Roscoe O. Brady, James M. Dambrosia et al.|New England Journal of Medicine|1991|1.3k